Clinical Trial Update: Pharmacokinetic Evaluation of Changes in Nevirapine AUC Due to Differences in Weight

View source ↗

Summary

This clinical trial update evaluates how Nevirapine exposure (AUC) varies with patient weight in individuals with HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• NEVIRAPINE (nevirapine)

Snippet

Sponsor: Western University of Health Sciences | Conditions: HIV Infection | Status: COMPLETED